Form D — Psy Therapeutics, Inc.
0001410578-25-002156 · filed 2025-09-12
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $20,400,000
- Total sold
- $6,762,848
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Psy Therapeutics, Inc.
- CIK
- 1788222
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 28 ATLANTIC AVE, SUITE 222
BOSTON, MA 02110 - Phone
- (617) 723-5429
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David S. Barlow · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Jeff Troderman · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Alan Cross · DirectorBoston, MA Find on LinkedIn ↗
-
Daniel Weiss Pick · DirectorBoston, MA Find on LinkedIn ↗
-
Jerry F. Rosenbaum · DirectorBoston, MA Find on LinkedIn ↗
-
William Wagner · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Paul Murphy · DirectorBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.